{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:37:52Z","timestamp":1778845072635,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.xphs.2020.02.011","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T19:48:08Z","timestamp":1582141688000},"page":"1967-1977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hydrophilic Poly(urethanes) Are an Effective Tool for Gastric Retention Independent of Drug Release Rate"],"prefix":"10.1016","volume":"109","author":[{"given":"Michael B.","family":"Lowinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther Y.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Robert O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2020.02.011_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1023\/A:1015870314340","article-title":"The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol","volume":"09","author":"Oth","year":"1992","journal-title":"Pharm Res"},{"issue":"7","key":"10.1016\/j.xphs.2020.02.011_bib2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3109\/03639049409038361","article-title":"\u201cIn-Vitro\u201d testing of an antacid formulation with prolonged gastric residence time (almagate flot-coat\u00ae)","volume":"20","author":"Fabregas","year":"1994","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-5173(92)90033-X","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate","volume":"86","author":"Hilton","year":"1992","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(00)00567-6","article-title":"Amoxycillin release from a floating dosage form based on alginates","volume":"210","author":"Whitehead","year":"2000","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2003.09.047","article-title":"Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms","volume":"277","author":"Hoffman","year":"2004","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2020.02.011_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/jps.2600801212","article-title":"A\u00a0new multiple-unit oral floating dosage system. II: in\u00a0vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs","volume":"80","author":"Ichikawa","year":"1991","journal-title":"J\u00a0Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2020.02.011_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1081\/DDC-100101309","article-title":"Studies of floating dosage forms of furosemide: in\u00a0vitro and in\u00a0vivo evaluations of bilayer tablet formulations","volume":"26","author":"\u00d6zdemir","year":"2000","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.011_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jps.2600550305","article-title":"Factors affecting the absorption of riboflavin in man","volume":"55","author":"Levy","year":"1966","journal-title":"J\u00a0Pharm Sci"},{"issue":"14","key":"10.1016\/j.xphs.2020.02.011_bib9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3109\/03639049209040859","article-title":"Novel drug delivery system for captopril","volume":"18","author":"Matharu","year":"1992","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.011_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/03639048409064653","article-title":"The hydrodynamically balanced system (HbsTM): a novel drug delivery system for oral use","volume":"10","author":"Sheth","year":"1984","journal-title":"Drug Dev Ind Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2020.02.011_bib11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3109\/03639049809089950","article-title":"In\u00a0vitro performance of floating sustained-release capsule of verapamil","volume":"24","author":"Chen","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2020.02.011_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1081\/DDC-100105175","article-title":"Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristics","volume":"27","author":"Soppimath","year":"2001","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.011_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/17425247.3.4.541","article-title":"Case studies in swelling polymeric gastric retentive tablets","volume":"3","author":"Berner","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"10.1016\/j.xphs.2020.02.011_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0016-5085(84)80178-X","article-title":"The physiology and pathophysiology of gastric emptying in humans","volume":"86","author":"Minami","year":"1984","journal-title":"Gastroenterology"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2012.04.044","article-title":"Decoupling the role of image size and calorie intake on gastric retention of swelling-based gastric retentive formulations: pre-screening in the dog model","volume":"431","author":"Lalloo","year":"2012","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-3659(97)00266-6","article-title":"Floating dosage forms: an in\u00a0vivo study demonstrating prolonged gastric retention","volume":"55","author":"Whitehead","year":"1998","journal-title":"J\u00a0Control Release"},{"issue":"9","key":"10.1016\/j.xphs.2020.02.011_bib17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1018921830385","article-title":"A\u00a0floating controlled-release drug delivery system: in\u00a0vitro-in\u00a0vivo evaluation","volume":"10","author":"Desai","year":"1993","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.011_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0378-5173(84)90154-6","article-title":"Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion","volume":"19","author":"Park","year":"1984","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.10.031","article-title":"Gastroretentive dosage forms: overview and special case of Helicobacter pylori","volume":"111","author":"Bardonnet","year":"2006","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.2042-7158.1987.tb07161.x","article-title":"The effect of polycarbophil on the gastric emptying of pellets","volume":"39","author":"Khosla","year":"1987","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0168-3659(90)90182-S","article-title":"GI transit of potential bioadhesive formulations in man: a scintigraphic study","volume":"12","author":"Harris","year":"1990","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5173(00)00600-1","article-title":"Comparative scintigraphic assessment of the intragastric distribution and residence of cholestyramine, Carbopol 934P and sucralfate","volume":"212","author":"Jackson","year":"2001","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.011_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/10717544.2013.877099","article-title":"Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability","volume":"22","author":"Patil","year":"2015","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2020.02.011_bib24","author":"Pandey"},{"issue":"8","key":"10.1016\/j.xphs.2020.02.011_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/pharmaceutics11080416","article-title":"In\u00a0vitro and in\u00a0vivo test methods for the evaluation of gastroretentive dosage forms","volume":"11","author":"Schneider","year":"2019","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.xphs.2020.02.011_bib26","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1023\/A:1020412817716","article-title":"Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs","volume":"19","author":"Klausner","year":"2002","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2020.02.011_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nmat4355","article-title":"A\u00a0pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices","volume":"14","author":"Zhang","year":"2015","journal-title":"Nat Mater"},{"issue":"365","key":"10.1016\/j.xphs.2020.02.011_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag2374","article-title":"Oral, ultra-long-lasting drug delivery: application toward malaria elimination goals","volume":"8","author":"Bellinger","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.xphs.2020.02.011_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejps.2013.11.018","article-title":"Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in\u00a0vivo verification in human studies","volume":"53","author":"Sugihara","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2006.02.038","article-title":"Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin","volume":"316","author":"Chavanpatil","year":"2006","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2020.02.011_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1023\/A:1012171010492","article-title":"Development of a novel controlled-release system for gastric retention","volume":"14","author":"Deshpande","year":"1997","journal-title":"Pharm Res"},{"issue":"1-3","key":"10.1016\/j.xphs.2020.02.011_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-3659(92)90071-X","article-title":"In\u00a0vitro and in\u00a0vivo studies of enzyme-digestible hydrogels for oral drug delivery","volume":"19","author":"Shalaby","year":"1992","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/00016926209171725","article-title":"Diameter of the pyloric aperture in relation to the contraction of the canalis egestorius","volume":"57","author":"Keet","year":"1962","journal-title":"Acta Radiol"},{"key":"10.1016\/j.xphs.2020.02.011_bib34","series-title":"Gastrointestinal Motility in Health and Disease","first-page":"349","article-title":"Direct measurement of pyloric diameter and tone in man and their response to cholecystokinin","author":"Munk","year":"1978"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.011_bib35","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jps.23467","article-title":"Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia","volume":"102","author":"Chen","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.011_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/088532828800300202","article-title":"Factors and interactions affecting the performance of polyurethane elastomers in medical devices","volume":"3","author":"Coury","year":"1988","journal-title":"J\u00a0Biomater Appl"},{"issue":"4","key":"10.1016\/j.xphs.2020.02.011_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/088532829500900402","article-title":"Polyurethane elastomer biostability","volume":"9","author":"Stokes","year":"1995","journal-title":"J\u00a0Biomater Appl"},{"issue":"9","key":"10.1016\/j.xphs.2020.02.011_bib38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/00912709922008506","article-title":"Microbial biofilms: their development and significance for medical device-related infections","volume":"39","author":"Habash","year":"1999","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1015847618671","article-title":"Hollow fibers as an oral sustained-release delivery system","volume":"06","author":"Hussain","year":"1989","journal-title":"Pharm Res"},{"issue":"2-3","key":"10.1016\/j.xphs.2020.02.011_bib40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(99)00270-9","article-title":"Linear type azo-containing polyurethane as drug-coating material for colon-specific delivery: its properties, degradation behavior, and utilization for drug formulation","volume":"66","author":"Yamaoka","year":"2000","journal-title":"J\u00a0Control Release"},{"issue":"16","key":"10.1016\/j.xphs.2020.02.011_bib41","doi-asserted-by":"crossref","first-page":"40650","DOI":"10.1002\/app.40650","article-title":"Synthesis of a novel pH-sensitive polyurethane-alginate blend with poly(ethylene terephthalate) waste for the oral delivery of protein","volume":"131","author":"Bhattacharyya","year":"2014","journal-title":"J\u00a0Appl Polym Sci"},{"key":"10.1016\/j.xphs.2020.02.011_bib42","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.msec.2016.07.017","article-title":"Facile preparation of pH-responsive polyurethane nanocarrier for oral delivery","volume":"69","author":"Nabid","year":"2016","journal-title":"Mater Sci Eng C"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.05.034","article-title":"Amphiphilic polyurethane hydrogels as smart carriers for acidic hydrophobic drugs","volume":"546","author":"Polo Fonseca","year":"2018","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2014.10.046","article-title":"Release characteristics of polyurethane tablets containing dicarboxylic acids as release modifiers \u2013 a case study with diprophylline","volume":"477","author":"Claeys","year":"2014","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2016.04.057","article-title":"Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding","volume":"506","author":"Verstraete","year":"2016","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.011_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/pharmaceutics10020055","article-title":"Sustained release drug delivery applications of polyurethanes","volume":"10","author":"Lowinger","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2020.02.011_bib47","doi-asserted-by":"crossref","first-page":"118550","DOI":"10.1016\/j.ijpharm.2019.118550","article-title":"How broadly can poly(urethane)-based implants be applied to drugs of varied properties?","volume":"568","author":"Lowinger","year":"2019","journal-title":"Int J Pharm"},{"issue":"16","key":"10.1016\/j.xphs.2020.02.011_bib48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM199904223401608","article-title":"Antiviral drugs","volume":"340","author":"Balfour","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.xphs.2020.02.011_bib49","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1002\/jps.23721","article-title":"Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties","volume":"102","author":"Bruni","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2020.02.011_bib50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1023\/A:1021720128725","article-title":"Aqueous solubilities, infinite dilution activity coefficients and octanol\u2013water partition coefficients of tricyclic analogs of acyclovir","volume":"28","author":"Zielenkiewicz","year":"1999","journal-title":"J\u00a0Solution Chem"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.011_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/03639040701655952","article-title":"In\u00a0vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers","volume":"34","author":"Shah","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2020.02.011_bib52","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/16.5.621","article-title":"Treatment of recurrent genital herpes simplex infections with oral acyclovir","volume":"16","author":"Ruhnek-Forsbeck","year":"1985","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.xphs.2020.02.011_bib53","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1023\/A:1015845031488","article-title":"Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles","volume":"09","author":"Park","year":"1992","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.011_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1208\/s12248-008-9039-2","article-title":"Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in\u00a0vitro and in\u00a0vivo evaluation","volume":"10","author":"Dhaliwal","year":"2008","journal-title":"AAPS J"},{"issue":"9","key":"10.1016\/j.xphs.2020.02.011_bib55","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3109\/03639041003677780","article-title":"Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere","volume":"36","author":"Liu","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2020.02.011_bib56","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3109\/03639045.2010.546404","article-title":"Optimization of acyclovir oral tablets based on gastroretention technology: factorial design analysis and physicochemical characterization studies","volume":"37","author":"El Gamal","year":"2011","journal-title":"Drug Dev Ind Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2020.02.011_bib57","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1248\/cpb.c12-00324","article-title":"Mucoadhesive tablets for controlled release of acyclovir","volume":"60","author":"Ruiz-Caro","year":"2012","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.xphs.2020.02.011_bib58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijpharm.2018.11.067","article-title":"Can drug release rate from implants be tailored using poly(urethane) mixtures?","volume":"557","author":"Lowinger","year":"2019","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.011_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/bdd.1828","article-title":"Size discrimination in rat and mouse gastric emptying","volume":"34","author":"Jang","year":"2013","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2020.02.011_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1208\/pt050234","article-title":"Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in\u00a0vitro evaluation","volume":"5","author":"Dave","year":"2004","journal-title":"AAPS PharmSciTech"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2005.08.009","article-title":"Development of sustained release gastroretentive drug delivery system for ofloxacin: in\u00a0vitro and in\u00a0vivo evaluation","volume":"304","author":"Chavanpatil","year":"2005","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2007.07.009","article-title":"Zero-order delivery of a highly soluble, low dose drug alfuzosin hydrochloride via gastro-retentive system","volume":"348","author":"Liu","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib63","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1208\/s12249-009-9200-y","article-title":"Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets","volume":"10","author":"Arza","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.011_bib64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1208\/s12249-009-9300-8","article-title":"Formulation and evaluation of gastroretentive drug delivery system of propranolol hydrochloride","volume":"10","author":"Jagdale","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"1-3","key":"10.1016\/j.xphs.2020.02.011_bib65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2009.10.015","article-title":"Development of swelling\/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism","volume":"39","author":"Chen","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-011-9711-1","article-title":"Optimization of a dual mechanism gastrofloatable and gastroadhesive delivery system for narrow absorption window drugs","volume":"13","author":"Murphy","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.02.011_bib67","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2012.12.002","article-title":"Physical characterizations and sustained release profiling of gastroretentive drug delivery systems with improved floating and swelling capabilities","volume":"441","author":"Chen","year":"2013","journal-title":"Int J Pharm"},{"issue":"1-3","key":"10.1016\/j.xphs.2020.02.011_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(99)00139-X","article-title":"Gastric retention properties of superporous hydrogel composites","volume":"64","author":"Chen","year":"2000","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jbm.a.30533","article-title":"Preparation and swelling behavior of chitosan-based superporous hydrogels for gastric retention application","volume":"76-A","author":"Park","year":"2006","journal-title":"J\u00a0Biomed Mater Res A"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.011_bib70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1211\/jpp.59.3.0001","article-title":"Recent developments in superporous hydrogels","volume":"59","author":"Omidian","year":"2007","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2020.02.011_bib71","series-title":"Application Number: 022544Orig1s000 Cross Discipline Team Leader Review","author":"Fields","year":"2010"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.011_bib72","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0091270010368411","article-title":"Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food","volume":"51","author":"Chen","year":"2011","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2020.02.011_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm Drug Dispos"},{"issue":"1-3","key":"10.1016\/j.xphs.2020.02.011_bib74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-5173(93)90029-F","article-title":"Gastrointestinal transit of a matrix tablet formulation: comparison of canine and human data","volume":"94","author":"Davis","year":"1993","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2020.02.011_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1016353705970","article-title":"Comparison of canine and human gastrointestinal physiology","volume":"03","author":"Dressman","year":"1986","journal-title":"Pharm Res"},{"issue":"18","key":"10.1016\/j.xphs.2020.02.011_bib76","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1073\/pnas.1002292107","article-title":"Understanding gastric forces calculated from high-resolution pill tracking","volume":"107","author":"Laulicht","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.xphs.2020.02.011_bib77","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(98)00400-1","article-title":"Gastrointestinal transit of pellets in rats: effect of size and density","volume":"180","author":"Tuleu","year":"1999","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2020.02.011_bib78","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2006.00761.x","article-title":"The risk of retention of the capsule endoscope in patients with known or suspected Crohn\u2019s disease","volume":"101","author":"Cheifetz","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.xphs.2020.02.011_bib79","first-page":"1037","article-title":"Duodenal obstruction: a complication of percutaneous endoscopic gastrostomy tube migration","volume":"85","author":"McGovern","year":"1990","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.xphs.2020.02.011_bib80","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11695-008-9786-2","article-title":"Efficacy, tolerance and safety of new intragastric air-filled balloon (heliosphere BAG) for obesity: the experience of 17 cases","volume":"20","author":"Trande","year":"2010","journal-title":"Obes Surg"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920300848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920300848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:28:16Z","timestamp":1758360496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920300848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0022354920300848"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.02.011","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrophilic Poly(urethanes) Are an Effective Tool for Gastric Retention Independent of Drug Release Rate","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}